✦ LIBER ✦

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes

✍ Scribed by Raskin, P.; Rappaport, E. B.; Cole, S. T.; Yan, Y.; Patwardhan, R.; Freed, M. I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ROSIGLITAZONE MODULATES FASTING AND POST

✍ Jeroen Van Wijk; Blai Coll; Manuel Castro Cabezas; Eelco Koning; Jordi Camps; To 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Repaglinide is more efficient than glime

✍ MR Rizzo; M Barbieri; R Grella; N Passariello; M Barone; G Paolisso 📂 Article 📅 2004 🏛 Masson Editeur 🌐 French ⚖ 115 KB

Effects of impaired fasting glucose and

✍ Jian-Jun Wang; Shen-Yuan Yuan; Liang-Xiang Zhu; Han-Jing Fu; Hong-Bing Li; Gang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Effects on post-prandial glucose and AGE

✍ Olga V. Sakharova; Ranee R. Lleva; James D. Dziura; Geralyn R. Spollett; Scott K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Short-term Glucose Metabolism and Gut Ho

✍ Zhang, Xiao-juan; Xiao, Zhu; Yu, Hong-ling; Zhang, Xiang-xun; Cheng, Zhong; Tian 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 463 KB

PDB56 Evaluating the Short-Term Cost-Eff

✍ J. Langer; B. Hunt; W.J. Valentine 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB